PER 2.44% 8.0¢ percheron therapeutics limited

Ann: Antisense Therapeutics Corporate Presentation, page-53

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    Ok, now our US patent application for ATL1102 use for DMD getting registered (though it can be challenged later) assumes much more importance.

    It would approximately double our protection window from 7 (ODD) to 13/14 yrs.

    May double our DMD future earnings and MC.
    Last edited by BoomCrashOffera: 29/08/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $58.49K 703.3K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 25545 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.